Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2002
03/14/2002WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a)
03/14/2002WO2001038302A3 Coupling condensation synthesis of heterocycles
03/14/2002US20020032328 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides
03/14/2002US20020032230 Dihydrofuranonyl- or dihydropyrrolinonyl-phenyl compounds containing substituted thio, sulfoxide or sulfonyl groups
03/14/2002US20020032222 Azolidines as beta-3 adrenergic receptor agonists
03/14/2002US20020032221 Treatment of HIV mediated diseases.
03/14/2002US20020032208 Chemical compounds
03/14/2002US20020032207 2-Cyclohexyl quinazoline NMDA/NR2B antagonists
03/14/2002US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
03/14/2002US20020032191 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors
03/14/2002US20020032174 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
03/14/2002CA2421213A1 The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
03/14/2002CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/13/2002EP1186606A1 Epothilone derivatives, their preparation and utilization
03/13/2002EP1185528A1 Inhibitors of il-12 production
03/13/2002EP1185526A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
03/13/2002EP1185525A1 4-heterocyclylsulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
03/13/2002EP1185521A1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors
03/13/2002EP1185519A1 Isothiazolecarboxamides and their use as microbicides
03/13/2002EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
03/13/2002EP0858452B1 Thiazole derivative as protein kinase c inhibitors
03/13/2002CN1340053A Epothilon derivatives, method for the production and the use as pharmaceuticals
03/13/2002CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists
03/13/2002CN1080720C 噻唑衍生物 Thiazole derivatives
03/12/2002US6355805 β3-adrenergic receptor agonists
03/12/2002US6355796 Reacting beta-amino-beta-(perfluoroalkyl)acrylate compound with base and carbamoyl chloride compound to form urea compound, reacting urea compound with phosphorus pentahalide or oxalyl halide
03/12/2002US6355680 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
03/12/2002US6355665 1H-4(5)-substituted imidazole derivatives, their preparation and their use as histamine H3 receptor ligands
03/12/2002US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents
03/12/2002US6355641 Oxazolone derivatives and uses thereof
03/12/2002US6355631 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
03/12/2002US6355441 Benzothiazole dioxetanes
03/12/2002CA2060393C Carbamic acid derivatives and method for preparing the same
03/12/2002CA2055947C Condensed heterocyclic compounds, their production and use
03/07/2002WO2002018354A1 Oxazolidinones and their use as antibacterial agents
03/07/2002WO2002018346A1 Pyrazole derivatives and their use as protein kinase inhibitors
03/07/2002WO2002017924A1 Method of treatment
03/07/2002WO2002017923A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
03/07/2002WO2002017915A1 Benzylidene thiazolidinediones and their use as antimycotic agents
03/07/2002WO2001089457A3 Thrombopoietin mimetics
03/07/2002WO2001077100A3 Benzoamide piperidine compounds as substance p antagonists
03/07/2002WO2001068645A3 N-cyanomethylcarboxamides and their use as protease inhibitors
03/07/2002WO2001057022A3 Pyrazole compositions useful as inhibitors of erk
03/07/2002US20020028950 Guanidinylamino heterocycle compunds useful as alpha-2 adrenoceptor agonists
03/07/2002US20020028835 Cyclic amine phenyl beta-3 adrenergic receptor agonists
03/07/2002US20020028834 Heterocyclic-cyclic amine derivatives
03/07/2002US20020028832 Substituted 4-((4-amino-5-hydroxyphenyl)-oxy-)piperidine analogs; metabolic disorders; antidiabetic agents; athero-sclerosis, gastrointestinal disorders, glaucoma, neurogenetic inflammation, ocular hypertension and frequent urination
03/07/2002US20020028810 Substituted N-( indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
03/07/2002US20020028809 Heterocyclic compounds having effect of activating a4beta2 nicotinic acetylcholine receptors
03/07/2002US20020028806 As a pour-on or spot-on on formulation for controlling parasites such as fleas in warm blooded animals; such as 2,2-dimethylbutyric acid, (1-((6-chloro-pyridin-3-ylmethyl)-ethyl-amino)-2-nitrovinyl)-methyl -carbamoyloxy)-methyl ester
03/07/2002US20020028797 Therapy for metabolism diseases; dietetics; antidiabetic agents
03/07/2002US20020028748 Chemical intermediates
03/07/2002CA2420804A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
03/07/2002CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors
03/06/2002EP1184382A1 Oxime derivatives, process for the preparation thereof and pesticides
03/06/2002EP1184373A1 Tricyclic compounds
03/06/2002EP1184368A1 Intermediates for pesticidal tris-oximino heterocyclic compounds
03/06/2002EP1184037A1 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
03/06/2002EP1183253A1 C7 ester substituted taxanes as antitumor agents
03/06/2002EP1183247A1 Polycyclic thiazole systems and their utilization as anorectics
03/06/2002EP1183245A1 Selective npy (y5) antagonists
03/06/2002EP1183242A2 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
03/06/2002EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
03/06/2002EP1183229A1 Glucagon antagonists/inverse agonists
03/06/2002EP0994865B1 Triazole compounds and the use thereof as dopamine-d 3-ligands
03/06/2002EP0728748B1 Benzodiazepine derivatives
03/06/2002CN1338454A Cyclic amino acid and cyclohydroxycarboxylic derivative substituted benzamidine derivatives and their uses as anticoagulants
03/05/2002US6353011 Drugs for endocrines and cardiovascular disorders
03/05/2002US6353010 Enzyme inhibitors tumor necrosis factor and phosphodiesterase for antiinflammatory agents
03/05/2002US6353007 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
03/05/2002US6353006 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
03/05/2002US6353001 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides
03/05/2002US6352994 Nervous system disorders; psychological disorders
03/05/2002US6352993 Pyrimidine derivatives and processes for the preparation thereof
03/05/2002US6352985 Benzimidazole compounds
03/05/2002US6352982 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
03/05/2002US6352981 Treat disorders which respond to dopamine d.sub.3 ligands such as schistosomiasis, schizophrenia, depression, neuroses or psychoses
03/05/2002CA2272138C Pyrazolopyrimidine and pyrazolopyridine compounds having crf antagonist activity
02/2002
02/28/2002WO2002016361A2 Nitrogenous heterocyclic compounds
02/28/2002WO2002016353A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders
02/28/2002WO2002016335A2 Catalytic process for the preparation of thiazole derivatives
02/28/2002WO2002016334A1 Continuous process for the preparation of pesticidal chlorothiazoles
02/28/2002WO2002016324A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
02/28/2002WO2002015909A1 Substituted piperidines as melanocortin receptor agonists
02/28/2002WO2001092255A3 Epothilone derivatives and methods for making and using the same
02/28/2002WO2001077080A3 Pyrazole compounds having anti proliferative activity
02/28/2002US20020026050 Thrombin receptor antagonists
02/28/2002US20020025976 Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use
02/28/2002US20020025974 Hypotensive agents; vision defects
02/28/2002US20020025973 Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
02/28/2002US20020025961 Platelet ADP receptor inhibitors
02/28/2002US20020025957 Anticoagulants, cardiovascular disorders
02/28/2002US20020025910 3-heterocycly1 - substituted benzoyl derivatives
02/28/2002DE10041470A1 New 6-substituted 12,13-(cyclopropyl or azacyclopropyl)-epothilone derivatives, useful as cell division regulators for treating e.g. malignant tumors, psoriasis or arthritis
02/28/2002CA2419310A1 Substituted piperidines as melanocortin receptor agonists
02/27/2002EP1182202A1 Aminomethylpyrrolidine derivatives having aromatic substituents
02/27/2002EP1181935A2 Agent for treating mental disorders associated with cerebrovascular disorders
02/27/2002EP1181294A1 Novel derivatives and analogues of galanthamin
02/27/2002EP1181283A1 Diaminothiazoles and their use for inhibiting protein kinases
02/27/2002EP1181282A2 Benzothiazinone and benzoxazinone compounds